Beta Drugs Financial Results

Beta Drugs Other Announcement

Beta Drugs Limited submitted its quarterly Statement of Deviation or Variation for the preferential issue proceeds, confirming no deviation from the stated objects.

Beta Drugs Earnings Call Transcript: Key Takeaways

Management projects a 20-25% growth trajectory despite Q2 bottlenecks. Recent acquisitions and niche oncology focus underpin expansion strategy.

Call

Guides 25% growth

Beta Drugs Investor Presentation: Key Takeaways

Beta Drugs reported H1 FY27 revenue of INR 263 Cr with EBITDA margins expanding to 23.2%. The firm is transitioning from a CMO to a branded specialty oncology powerhouse.

Beta Drugs Q2 FY27 Results: Net Profit ₹18.55 Cr, Up 51.8% YoY

Beta Drugs Ltd reported revenue from operations of ₹137.5 Cr (+33.0% YoY) and net profit of ₹18.55 Cr (+51.8% YoY) for Q2 FY27.

Key figure

Net profit ₹18.55 Cr · +51.8% YoY

Beta Drugs Board Meeting Date

Beta Drugs Limited notified the exchange of a board meeting scheduled for 22-Oct-2026 to consider quarterly financial results. The trading window closure was also intimated.

Beta Drugs Annual General Meeting

Beta Drugs Limited conducted its 21st Annual General Meeting on September 30, 2026. Shareholders considered resolutions including financial statement adoption, director re-appointments, and auditor ratification.

Velox Shipping and Logistics Q2 FY27 Results: Net Profit ₹0.8 Cr, Up 166.7% YoY

Velox Shipping and Logistics Ltd reported revenue from operations of ₹2.5 Cr and net profit of ₹0.8 Cr (+166.7% YoY) for Q2 FY27.

Key figure

Net profit ₹0.8 Cr · +166.7% YoY

Ecofinity Atomix Q2 FY27 Results: Net Profit ₹0.7 Cr, Up 16.7% YoY

Ecofinity Atomix Ltd reported revenue from operations of ₹26.5 Cr (+145.4% YoY) and net profit of ₹0.7 Cr (+16.7% YoY) for Q2 FY27.

Key figure

Net profit ₹0.7 Cr · +16.7% YoY

Transglobe Foods Q2 FY27 Results: Net Profit ₹0 Cr

Transglobe Foods reported unaudited Q2 and H1 FY27 results for the period ended 30 September 2026. The half-year net loss was ₹3.49 lakhs, with going-concern doubts noted.

Key figure

Net profit ₹0 Cr

Euro India Fresh Foods Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr

Euro India Fresh Foods Ltd reported revenue from operations of ₹29.9 Cr (-8.0% YoY) and net profit of ₹0.1 Cr for Q2 FY27.

Key figure

Net profit ₹0.1 Cr

Market Creators Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr

Market Creators Ltd reported revenue from operations of ₹1.4 Cr (+16.7% YoY) and net profit of ₹0.1 Cr for Q2 FY27.

Key figure

Net profit ₹0.1 Cr

Sharma East India Hospitals & Medical Research Q2 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY

Sharma East India Hospitals & Medical Research Ltd reported revenue from operations of ₹10.4 Cr (+10.6% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q2 FY27.

Key figure

Net profit ₹0.3 Cr · +0.0% YoY